<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A total of 261 adverse ocular reactions occurred in 237 patients who received <z:chebi fb="0" ids="6067">isotretinoin</z:chebi>, a commonly used drug in the treatment of severe cystic <z:hpo ids='HP_0001061'>acne</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0005743" disease_type="Disease or Syndrome" abbrv="">Blepharoconjunctivitis</z:e>, subjective complaints of <z:mp ids='MP_0001337'>dry eyes</z:mp>, <z:hpo ids='HP_0000622'>blurred vision</z:hpo>, contact lens intolerance, and <z:e sem="disease" ids="C0031762" disease_type="Disease or Syndrome" abbrv="">photodermatitis</z:e> are reversible side effects </plain></SENT>
<SENT sid="2" pm="."><plain>More serious ocular adverse reactions include <z:hpo ids='HP_0001085'>papilledema</z:hpo>, <z:e sem="disease" ids="C0033845" disease_type="Disease or Syndrome" abbrv="">pseudotumor cerebri</z:e>, and white or gray <z:hpo ids='HP_0008039'>subepithelial corneal opacities</z:hpo>; <z:hpo ids='HP_0000001'>all</z:hpo> of these are reversible if the drug is discontinued </plain></SENT>
<SENT sid="3" pm="."><plain>Reported cases of decreased dark adaptation are under investigation </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="6067">Isotretinoin</z:chebi> is contraindicated in pregnancy because of the many reported congenital abnormalities after maternal use (including <z:hpo ids='HP_0000568'>microphthalmos</z:hpo>, orbital <z:hpo ids='HP_0000316'>hypertelorism</z:hpo>, and <z:hpo ids='HP_0000609'>optic nerve hypoplasia</z:hpo>) </plain></SENT>
</text></document>